Lupin receives USFDA approval for Generic Lumigan Ophthalmic Solution 0.03%

Lupin has received final approval for its Bimatoprost Ophthalmic Solution, 0.03 percent from the USFDA to market a generic version of Allergan Inc.�s Lumigan Ophthamic Solution, 0.03 percent.

Lupin Ltd has informed BSE regarding a Press Release dated February 23, 2015 titled "Lupin Receives US FDA Approval for Generic Lumigan® Ophthalmic Solution 0.03%". Lupin has received final approval for its Bimatoprost Ophthalmic Solution, 0.03 percent from the USFDA to market a generic version of Allergan Inc.�s Lumigan Ophthamic Solution, 0.03 percent.Source : BSE

Read all announcements in Lupin

To read the full report click here

Anda sedang membaca artikel tentang

Lupin receives USFDA approval for Generic Lumigan Ophthalmic Solution 0.03%

Dengan url

http://sehatgayahidup.blogspot.com/2015/02/lupin-receives-usfda-approval-for.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Lupin receives USFDA approval for Generic Lumigan Ophthalmic Solution 0.03%

namun jangan lupa untuk meletakkan link

Lupin receives USFDA approval for Generic Lumigan Ophthalmic Solution 0.03%

sebagai sumbernya